Kevin Eisenfrats

Kevin Eisenfrats is the founder and chief executive of Contraline, a company that is pioneering non-hormonal male contraceptive solutions. He has been instrumental in developing 'Adam', an innovative implantable hydrogel contraceptive that effectively blocks sperm release for up to two years. Eisenfrats is driven by the goal of providing a reversible alternative to traditional contraceptive methods, with a focus on user-friendly and minimally invasive procedures.